97340 ⎘
Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
Virulence Attenuated Bacteria Based Protein Delivery
#2DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#3SINGLE-DOMAIN HIGH AFFINITY ANTIBODIES AND METHODS OF USE THEREOF
#4NANOPARTICLE FORMULATIONS
#5COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS
#6TARGETING MODULES AGAINST IL13R-alpha-2 AND/OR HER2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR-MEDIATED IMMUNE RESPONSE IN A MAMMAL
#7IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES THEREOF
#8METHOD FOR SCREENING ALPHA BETA-TCR HETERODIMER MUTANTS
#9RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2
#10PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS
#11IMMUNOREACTIVE PEPTIDES
#12HV1 MODULATORS AND USES
#13COMPOSITIONS AND METHODS USEFUL IN PROMOTING MILK PRODUCTION
#14ERYTHROCYTE-BINDING THERAPEUTICS
#15NON-CYTOTOXIC MODIFIED CELLS AND USE THEREOF
#16METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES
#17Immunoreactive peptides
#18PROTEIN SCREENING AND DETECTION METHOD
#19ERYTHROCYTE-BINDING THERAPEUTICS
#20TCRS SPECIFIC FOR MINOR HISTOCOMPATIBILITY (H) ANTIGEN HA-1 AND USES THEREOF
#21CD19-Directed Chimeric Antigen Receptor Constructs
#22NUCLEASE WITH IMPROVED TARGETING ACTIVITY
#23BINDING PROTEINS RECOGNIZING HA-2 ANTIGEN AND USES THEREOF
#24HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES
#25Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
#26SELF-REGULATING AAV VECTORS FOR SAFE EXPRESSION OF MECP2 IN RETT SYNDROME
#27COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED CELL MODULATION
#28Virulence Attenuated Bacteria Based Protein Delivery
#29ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF
#30VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS
#31DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN CELLULAR IMMUNOTHERAPY
#32A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE IN A MAMMAL
#33ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF
#34SWI/SNF FAMILY CHROMATIN REMODELING COMPLEXES AND USES THEREOF
#35REGULATABLE CHIMERIC ANTIGEN RECEPTOR
#36COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS
#37Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#38METHODS AND COMPOSITIONS FOR REDUCING THE IMMUNOGENICITY OF CHIMERIC NOTCH RECEPTORS
#39HV1 modulators and uses
#40Anti-podocalyxin antibodies and methods of using the same
#41PEPTIDE-LOADED CARRIER SYSTEMS AND USES THEREOF
#42IMPROVED THERAPEUTIC METHOD FOR RARE OCULAR DISEASES BY GENE REPLACEMENT
#43SINGLE DOMAIN ANTIBODIES AGAINST CLL-1
#44Variant ICOS ligand immunomodulatory proteins and related compositions and methods
#45NANOPARTICLE FORMULATIONS
#46N- and C-terminal tandem tag system for purification
#47GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE
#48ApoC-II mimetic peptides
#49IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
#50Methods for the production of therapeutic, diagnostic, or research antibodies
#51Erythrocyte-binding therapeutics
#52DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#53IL13Rα2 binding agents and use thereof
#54CELL SORTING SYSTEMS AND METHODS OF USE
#55LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE
#56Erythrocyte-binding therapeutics
#57PD-L1 binding fibronectin type III domains
#58DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#59Synthetic extracellular vesicles for novel therapies
#60Compositions and methods useful in promoting milk production
#61Genome engineering with type I CRISPR systems in eukaryotic cells
#62VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS
#63Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#64TCRS SPECIFIC FOR MINOR HISTOCOMPATIBILITY (H) ANTIGEN HA-1 AND USES THEREOF
#65A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#66De novo binding domain containing polypeptides and uses thereof
#67Nanoparticle formulations
#68TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof
#69Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome
#70FUSION POLYPEPTIDE AND METHOD FOR PRODUCING FUSION POLYPEPTIDE
#71ApoC-II mimetic peptides
#72Virulence attenuated bacteria based protein delivery
#73Antigen-specific tolerance and compositions for induction of same
#74Light-gated signaling modulation
#75Erythrocyte-binding therapeutics
#76Amino acid sequence presenting fusion polypeptide and its use
#77DNA polymerase variant and application thereof
#78HV1 modulators and uses
#79Conjugates of IL13Rα2 binding agents and use thereof in cancer treatment
#80Protein screening and detection method
#81Regulatable chimeric antigen receptor
#82Non-cytotoxic modified cells and use thereof
#83TCRS specific for minor histocompatibility (H) antigen HA-1 and uses thereof
#84Methods of transcription activator like effector assembly
#85Botulinum neurotoxin and its derivatives
#86Methods of making gels and films using curli nanofibers
#87Methods for the production of therapeutic, diagnostic, or research antibodies
#88Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#89Genome engineering with Type I CRISPR systems in eukaryotic cells
#90TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof
#91Anti-podocalyxin antibodies and methods of using the same
#92Endoglin polypeptides and uses thereof
#93De novo binding domain containing polypeptides and uses thereof
#94De novo binding domain containing polypeptides and uses thereof
#95Antigen-specific tolerance and compositions for induction of same
#96Compositions for generation of immune tolerance to specific antigens
#97Compositions for inducing antigen-specific tolerance
#98Libraries of modified fibronectin type III tenth domain-containing polypeptides
#99Nanoparticle formulations
#100Method for screening pharmaceuticals for treatment of steatohepatitis using N-terminal dimerization of apoptosis signal-regulated kinase1
#101IL13Rα2 binding agents and use thereof in cancer treatment
#102PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment
#103Erythrocyte-binding therapeutics
#104Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#105Compositions comprising GRIM-19 therapeutics and methods of use
#106Construct for the delivery of a molecule into the cytoplasm of a cell
#107Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
#108Bispecific antibody fragments for neurological disease proteins and methods of use
#109Erythrocyte-binding therapeutics
#110Methods for reducing immune responses
#111Compositions for inducing antigen-specific tolerance
#112Methods for induction of antigen-specific immune tolerance
#113Compositions for generating immune tolerance by targeting erythrocytes
#114Alternative splicing variant of OATP1B3 mRNA
#115Methods of transcription activator like effector assembly
#116Methods of Improving the Therapeutic Efficacy and Utility of Antibody Fragments
#117TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof
#118Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VHH domain
#119Amino acid sequence presenting fusion polypeptide and its use
#120Antibody specifically binding to insulin-like growth factor-1
#121Method for refining protein including self-cutting cassette and use thereof
#122Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
#123Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein
#124Single domain antibodies against SOD1 and their use in medicine
#125Gene from tidal flat metagenome and a novel protein displaying both phospholipase and lipase activities
#126IL-33R and IL-1RAcP fusion proteins
#127Endoglin polypeptides and uses thereof
#128FGF-10 COMPLEXES
#129Recognition tags for TGase-mediated conjugation
#130Diagnostic method for detecting an autoimmune disease
#131TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof
#132Neuroprotective peptides that inhibit interaction between palmitoyl acyl transferase zinc-finger DHHC type containing 17 (zD17) and c-jun N-terminal kinase (JNK)
#133Pregnancy-associated plasma protein-A2 (PAPP-A2) polypeptides
#134AKT ligands and polynucleotides encoding AKT ligands
#135Wnt compositions and therapeutic uses of such compositions
#136Nitration shielding peptides and methods of use thereof
#137PCR reaction mixtures with decreased non-specific activity
#138MOLECULAR AND CELLULAR IMAGING USING ENGINEERED HEMODYNAMIC RESPONSES
#139Erythrocyte-binding therapeutics
#140Bispecific antibody fragments for neurological disease proteins and methods of use
#141HSA-related compositions and methods of use
#142Bispecific anti-EGFR/anti IGF-1R antibodies
#143mTOR ligands and polynucleotides encoding mTOR ligands
#144Amino acid sequence presenting fusion polypeptide and its use
#145WDR13 as a novel biomarker useful for treating diabetes and cancer
#146Wnt compositions and therapeutic uses of such compositions
#147Therapeutic peptides and use thereof against huntington's disease
#148Antibody specifically binding to insulin-like growth factor-1
#149Alternative splicing variant of OATP1B3 mRNA
#150Anti-serum albumin binding variants
#151Protease screening methods and proteases identified thereby
#152Biocatalysts and methods for the synthesis of ()-3-(1-aminoethyl)-phenol
#153Compositions and methods for increasing serum half-life
#154Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#155Method for producing cAMP using chimeric olfactory receptor
#156HSA-related compositions and methods of use
#157Preparation and/or purification of oligonucleotide conjugates
#158Factor VIII Compositions and Methods of Making and Using Same
#159NOVEL REPORTER-TAGGED RECOMBINANT MEMBRANE PROTEINS WITH TRANSMEMBRANE LINKERS
#160Protease screening methods and proteases identified thereby
#161Isolated laminin-421
#162PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY
#163Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
#164RADIOLABELED COMPOUND DIRECTABLE IN VIVO TO TARGET TISSUE AND USE THEREOF
#165PCR reaction mixtures with decreased non-specific activity
#166CONSTRUCTS THAT ALLOW FOR DETECTION AND QUANTITATION OF MEMBRANE PROTEINS
#167Diagnosis of depression
#168FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#169Erythrocyte-binding therapeutics
#170MOLECULES WITH EXTENDED HALF-LIVES AND USES THEREOF
#171METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#172Therapeutic approach to neurodegenerative disorders using a TFP5-peptide
#173VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS
#174Carboxy terminal residues as predictors and regulators of protein stability
#175Amino acid sequences which enhance peptide conjugate solubility
#176Erythrocyte-binding therapeutics
#177METHODS OF IMPROVING THE THERAPEUTIC EFFICACY AND UTILITY OF ANTIBODY FRAGMENTS
#178Mucin derived polypeptides
#179Alternative splicing variant of OATP1B3 mRNA
#180Triple tag sequences and methods of use thereof
#181BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#182Viral Sequences and Uses Thereof
#183AKT ligands and polynucleotides encoding AKT ligands
#184Cognate sampling kinetics
#185Peptides for inhibiting the HPV-E6 oncoprotein
#186Process for producing hepcidin
#187METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX
#188Immunomodulatory protein and useful embodiments thereof
#189METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#190METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#191Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
#192mTOR ligands and polynucleotides encoding mTOR ligands
#193Triple tag sequence and methods of use thereof
#194Novel therapeutic and diagnostic products and methods
#195METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#196Epitope-tag surface expressed proteins and nucleic acids thereof
#197Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy
#198Trimerising module
#199ALTERNATIVE OXIDASE AND USES THEREOF
#200Trimerising module
#201PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#202Soluble Fragments of The Sars-Cov Spike Glycoprotein
#203ALTERED VIRUS CAPSID PROTEIN AND USE THEREOF
#204AKT ligands and polynucleotides encoding AKT ligands
#205Selection system
#206METHOD FOR PRODUCTION OF CYTOCHROME P450 WITH N-TERMINAL TRUNCATED P450 REDUCTASE
#207Selection
#208METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#209Attenuated RNA virus and applications thereof
#210Protease screening methods and proteases identified thereby
#211Virus coat protein/receptor chimeras and methods of use
#212BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#213Immunomodulatory protein and useful embodiments thereof
#214Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
#215mTOR ligands and polynucleotides encoding mTOR ligands
#216Alternative oxidase and uses thereof
#217PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#218PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#219Excretable Reporter Systems
#220CLONING, CHARACTERIZATION, AND APPLICATION OF TNFRSF19 IN NEUROLOGICAL DISORDERS
#221Methods for production of receptor and ligand isoforms
#222Pharmacokinetic modulation and compositions for modified FN3 polypeptides
#223Trimerising module
#224METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#225Inhibitors of type 2 vascular endothelial growth factor receptors
#226Pregnancy-associated plasma protein-A2 (PAPP-A2)
#227Probes for analyzing interaction between proteins and method of analyzing interaction between proteins using the same
#228Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy
#229Soluble fragments of the SARS-CoV spike glycoprotein
#230Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases
#231Multi-reporter gene model for toxicological screening
#232Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
#233Virus coat protein/receptor chimeras and method of use
#234Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrix
#235Test systems and the use thereof for identifying and characterizing compounds
#236Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#237Transgenic mice expressing inducible human p25